Evidence map›Paper›PMID 39837928›Full record

ArticleScientific reports2025

Tailoring PbTe quantum dot Size and morphology via ligand composition.

Svetlana Lyssenko, Michal Amar, Alina Sermiagin, Ayan Barbora, Refael Minnes

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Svetlana LyssenkoDepartment of Physics, Ariel University, Ariel, 40700, Israel.
Michal AmarDepartment of Physics, Ariel University, Ariel, 40700, Israel.
Alina SermiaginDepartment of Physics, Ariel University, Ariel, 40700, Israel.
Ayan BarboraDepartment of Physics, Ariel University, Ariel, 40700, Israel.
Refael MinnesDepartment of Physics, Ariel University, Ariel, 40700, Israel. refaelm@ariel.ac.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The literature shows a lack of significant research on the synthesis of large spherical PbTe quantum dots (QDs), particularly with controllable sizes and morphology. Here, we present for the first time a novel hot-injection method for the tunable, high-quality synthesis of cubooctahedral PbTe QDs within the size range of 10 nm to 16 nm. This method employs a combination of oleic acid (OA) with shorter carboxylic acids, including octanoic (OctA), decanoic (DA), and lauric acids (LA), tested at various volumetric ratios. Our investigation reveals that different ratios of these acids result in diverse morphologies. Lower concentrations (0.5:5.5 and 1:5) favor cubical morphologies while increasing the concentration of short ligands induces a transformation to cubooctahedral shapes. This shape change is associated with the disruption of nanocrystal (NC) crystallinity. Higher ratios of short ligands produce PbTe NCs with a crystallite core and an amorphous shell. Our findings demonstrate the tunability and precise control achieved with this mixed capping ligand hot-injection method, which significantly impacts QD applications in photovoltaics, electronics, and energy. Notably, shorter capping ligand (OctA) result in more monodispersed PbTe QDs, yielding larger cubooctahedral QDs up to 16 nm. Conversely, using capping ligands with lengths similar to OA leads to unstable and less tunable synthesis.

Indexed as

Core-shellHot-injectionOleic acidPbTe QDsShort ligandsSize manipulation

Identifiers

PMID39837928
PMCPMC11751075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.